AIM2 and atherosclerosis: In contrast to TET2 and DNMT3A, where NLRP3 inflammasome activation appears predominant as a mechanism that drives accelerated atherosclerosis, recent data suggest that ASXL1 and JAK2 CHIP provoke activation of the AIM2 inflammasome (Table 1).